Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Clinical Trial Comparing the Safety and Effectiveness of Axon Therapy and Conventional Medical Management (AT+CMM) for the Treatment of Painful Diabetic Neuropathy to Sham and Conventional Medical Management (Sham+CMM)

NCT05620225 is registered in ClinicalTrials.gov with NeuraLace Medical, Inc. as lead sponsor.

NCT NCT05620225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05620225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Clinical Trial Comparing the Safety and Effectiveness of Axon Therapy and Conventional Medical Management (AT+CMM) for the Treatment of Painful Diabetic Neuropathy to Sham and Conventional Medical Management (Sham+CMM)
Lead sponsor
NeuraLace Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2022
Completion date
November 22, 2023
Enrollment
93 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

neuralgia, neuropathic pain, painful diabetic neuropathy